Research Associate (Jackson Group) (Fixed Term)
at University of Cambridge
Cambridge, England, United Kingdom -
Start Date | Expiry Date | Salary | Posted On | Experience | Skills | Telecommute | Sponsor Visa |
---|---|---|---|---|---|---|---|
Immediate | 05 Nov, 2024 | GBP 44263 Annual | 19 Oct, 2024 | N/A | Good communication skills | No | No |
Required Visa Status:
Citizen | GC |
US Citizen | Student Visa |
H1B | CPT |
OPT | H4 Spouse of H1B |
GC Green Card |
Employment Type:
Full Time | Part Time |
Permanent | Independent - 1099 |
Contract – W2 | C2H Independent |
C2H W2 | Contract – Corp 2 Corp |
Contract to Hire – Corp 2 Corp |
Description:
We are looking for a talented and motivated postdoctoral scientist to join the lab of Professor Sir Steve Jackson (https://www.stevejacksonlab.org/), based in the internationally renowned Cancer Research UK Cambridge Institute https://www.cruk.cam.ac.uk/, located on the Cambridge Biomedical Campus, Cambridge, UK.
Radiotherapy is a mainstay of cancer treatment, but we still do not understand completely why some patients respond well and others do not. Further research is needed to understand the biology of radiosensitivity/resistance and exploit this knowledge to improve patient outcomes. This CRUK RadNet Cambridge-funded project will explore the cell biology of radiation-induced DNA damage to exploit/counteract radioresistance.
The postholder will:
- Design and conduct high-throughput CRISPR screens in human tissue culture cells to explore sensitivity/resistance mechanisms to ionising radiation (IR).
- From these studies, establish how defects and deregulation of certain DNA damage response (DDR) and other cellular processes affect sensitivity and resistance to IR; and identify the potential clinical relevance of these effects in cancer.
- Generate multiple gene knockout and endogenous-degron tagged cell lines that target these resistance and sensitivity processes.
- Carry out follow-up validation and ensuing mechanistic studies - including further high-throughput CRISPR screens - to fully characterise these novel genetic and functional relationships.
The work will be multi-disciplinary, combining recently established genome engineering and genetic screening approaches in human cells with next-generation sequencing, bioinformatics, cell biology, molecular biology and biochemistry.
Responsibilities:
Please refer the Job description for details
REQUIREMENT SUMMARY
Min:N/AMax:5.0 year(s)
Information Technology/IT
Pharma / Biotech / Healthcare / Medical / R&D
Software Engineering
Trade Certificate
Please do not send academic certificates at this stage.
Proficient
1
Cambridge, United Kingdom